Dr. Patricia Chavez, MD

Dr. Chavez practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Chavez's NPI, 1710273990, was assigned on June 25, 2011. Dr. Chavez holds Connecticut license 75308.

Dr. Chavez's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Chavez's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. Dr. Chavez is also affiliated with Yale New Haven Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Chavez to 2 more hospitals, 2 medical groups and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chavez practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chavez's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Chavez's licenses on file in 2 states: Connecticut and New York.

CMS data shows 867 Medicare services from Dr. Chavez across 12 procedure codes in 2024, for 477 Medicare patients. Medicare paid $65,404 for them.

CMS counts 477 Medicare patients who saw Dr. Chavez in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chavez's median patient age at 73, with 53% women.

In 2024, Dr. Chavez wrote 389 Medicare Part D claims for 117 patients. 77% of them were for generic drugs. CMS names the drug for 271 of them, across 9 drugs with 11 or more claims each, at $671,619 in total drug cost. In 2023, CMS named 228 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Chavez for performance year 2024, reported as part of a group. Dr. Chavez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Chavez, published from 2013 to 2025. 2014 was the busiest year, with 4. The most frequent topics are Chest Pain, Coronary Angiography and Electrocardiography. Dr. Chavez has published most often in Am J Cardiol. Dr. Chavez's most frequent co-authors are Ulrich Peter Jorde, MD, Snehal R. Patel, MD and Edgar Argulian, MD, MPH.

Dmand AI links Dr. Chavez to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Tricuspid Valve Insufficiency and Gastroesophageal Reflux.

CMS Open Payments shows 10 general payments to Dr. Chavez from 6 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 69% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $133.